PlainRecalls
FDA Drug Low Class III Terminated

Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mL NDC# 0023-9211-03; b) 5 mL (NDC# 0023-9211-05); c) 10 mL (NDC# 0023-9211-10); d) 15 mL (NDC# 0023-9211-15) bottles, Manufactured By: Allergan, Irvine, CA 92612..

Reported: November 22, 2017 Initiated: October 19, 2017 #D-0077-2018

Product Description

Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mL NDC# 0023-9211-03; b) 5 mL (NDC# 0023-9211-05); c) 10 mL (NDC# 0023-9211-10); d) 15 mL (NDC# 0023-9211-15) bottles, Manufactured By: Allergan, Irvine, CA 92612..

Reason for Recall

Failed Impurities/Degradation Specifications.

Details

Recalling Firm
Allergan Sales, LLC
Units Affected
715,041 bottles
Distribution
Nationwide and Barbados, Curacao, Dominican Republic, Guyana, Jamaica, and Trinidad and Tobago.
Location
Waco, TX

Frequently Asked Questions

What product was recalled?
Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mL NDC# 0023-9211-03; b) 5 mL (NDC# 0023-9211-05); c) 10 mL (NDC# 0023-9211-10); d) 15 mL (NDC# 0023-9211-15) bottles, Manufactured By: Allergan, Irvine, CA 92612... Recalled by Allergan Sales, LLC. Units affected: 715,041 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 22, 2017. Severity: Low. Recall number: D-0077-2018.